Form 4: Summit Partners Sells 5.9M LifeStance Health Shares

Director Darren M. Black reports the sale of 5,899,661 shares of LifeStance Health Group, Inc. by affiliated Summit Partners entities.

Summary

• Reporting person Darren M. Black, a director at LifeStance Health Group, Inc., disclosed the sale of 5,899,661 shares of common stock.
• The shares were sold at a price of $8.02 per share.
• The transaction occurred on May 12, 2026.
• Following the sale, the reporting entities retain beneficial ownership of 23,310,115 shares.
• The shares were held by various Summit Partners investment funds.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as neutral to slightly negative, as large institutional selling often creates technical selling pressure, though it is a routine event for private equity lifecycle management.

Positives

• The transaction represents a standard portfolio rebalancing or exit strategy by a private equity investor rather than an operational failure.

Negatives

• Significant block sale of 5.9 million shares may create short-term downward pressure on the stock price due to increased supply.

Risks

• Large-scale divestment by a major institutional shareholder can signal a lack of long-term confidence or the end of a private equity investment cycle.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that large-scale divestments by private equity firms like Summit Partners are common as funds reach the end of their investment horizons, and this activity is typical for companies that have been public for several years.

Comparison to Industry Standards

• The sale is consistent with typical exit timelines for private equity firms post-IPO.
• The volume of shares sold is significant but reflects the large initial stake held by the Summit Partners funds.

Related Party Transactions

• The transaction involves multiple Summit Partners funds where Darren M. Black serves as a Managing Director.

Stakeholder Impact

• Shareholders may experience increased volatility in the short term due to the large volume of shares hitting the market.

Next Steps

• Monitor future Form 4 filings for further divestment activity by Summit Partners.

Key Dates

Recommendation

The sale is a technical event related to a private equity exit rather than a change in the fundamental business outlook of LifeStance Health; investors should hold until the market absorbs the supply.

Keywords

LifeStance Health, LFST, Insider Trading, Summit Partners, Form 4, Equity Sale